If lung cancer has appeared in your family, one of the first questions that comes to mind is whether genetic testing for lung cancer is something you should consider. It is a reasonable question, and the answer depends on your specific family pattern.
Share this BLOG article
Lung cancer is less strongly linked to inherited risk than breast or colorectal cancer. But inherited factors do play a role, and for some families, a genetic pattern is worth understanding before anything goes wrong. This guide is for people who want to be proactive: those with a family history of lung cancer, those wondering whether their risk is elevated, and those trying to understand what steps make sense now.
Can Lung Cancer Run in Families?
The short answer is yes, but with an important nuance. Lung cancer is primarily caused by environmental factors. Smoking remains the dominant cause of lung cancer, responsible for approximately 80–90% of cases (U.S. Centers for Disease Control and Prevention). But not everyone who smokes develops lung cancer, and not everyone diagnosed with lung cancer has a smoking history. That gap is partly explained by genetics.
Having a first-degree relative, meaning a parent, sibling, or child, who developed lung cancer, modestly increases your own risk by approximately 1.5 to 2 times, even after accounting for shared smoking habits in the family. This suggests that some people carry an inherited biological susceptibility to lung cancer, even if the specific genes responsible are not as clearly defined as they are for other cancer types.
When Lung Cancer Is More Likely to Have a Hereditary Component
Lung cancer is not commonly classified as a hereditary cancer, meaning there is no dominant inherited mutation that dramatically elevates lung cancer risk the way BRCA1/BRCA2 elevates breast and ovarian cancer risk. (American Cancer Society)
However, certain family history patterns may still suggest inherited risk:
Lung cancer diagnosed at a young age, before 50, in a family member who did not smoke or smoked very little
Multiple relatives on the same side of the family with lung cancer
Lung cancer appearing alongside other cancers in the family, such as breast cancer, brain tumors, sarcomas, or colorectal cancer, which may point to a hereditary syndrome
A family history of a known hereditary cancer syndrome, such as Li-Fraumeni syndrome or Lynch syndrome
If any of these patterns sound familiar, your family history is worth discussing with a physician or genetic counselor.
If you or someone you love has just been diagnosed with lung cancer, tumor genomic testing is the immediate priority. If you are a family member wondering whether lung cancer risk is inherited, the hereditary testing section later in this article addresses that directly. (NCI, Targeted Therapies)
Two Types of Genetic Testing for Lung Cancer: Which Applies to You?
Factor
Tumor Genomic Testing
Hereditary Risk Testing
What it analyzes
Tumor DNA
Gene changes inside the lung cancer tumor
Inherited DNA
The DNA you were born with, inherited from your parents
When you need it
After a lung cancer diagnosis, before treatment begins
If family history suggests a hereditary syndrome
Sample needed
Biopsy tissue from the tumor
Cheek swab, saliva, or blood draw
Purpose
Identify targetable mutations to select the most effective treatment
Assess inherited cancer risk
What it analyzes
Tumor Genomic Testing
Gene changes inside the lung cancer tumor
Hereditary Risk Testing
The DNA you were born with, inherited from your parents
When you need it
Tumor Genomic Testing
After a lung cancer diagnosis, before treatment begins
Hereditary Risk Testing
If family history suggests a hereditary syndrome
Sample needed
Tumor Genomic Testing
Biopsy tissue from the tumor
Hereditary Risk Testing
Cheek swab, saliva, or blood draw
Purpose
Tumor Genomic Testing
Identify targetable mutations to select the most effective treatment
Hereditary Risk Testing
Assess inherited cancer risk
For a newly diagnosed lung cancer patient, tumor genomic testing is the immediate priority. Hereditary risk testing is relevant only in specific family history situations.
Source: NCCN, ASCO
Which Inherited Gene Changes Are Linked to Lung Cancer Risk?
Unlike breast or ovarian cancer, lung cancer is not currently linked to one well-established inherited gene that dramatically elevates risk across the population. The hereditary picture is more nuanced. However, several known inherited conditions do include lung cancer in their risk profiles.
Li-Fraumeni Syndrome (TP53)
Li-Fraumeni syndrome is a rare but serious hereditary cancer condition caused by an inherited change in the TP53 gene. TP53 normally acts as the body's master tumor suppressor, instructing damaged cells to stop growing before they can become cancerous. When a harmful TP53 change is inherited, that protection is significantly weakened.
People with Li-Fraumeni syndrome face elevated risk across multiple cancer types, including breast cancer, brain tumors, bone and soft tissue sarcomas, adrenocortical carcinoma, and lung cancer. The syndrome is rare, but because it is high-penetrance, meaning the lifetime cancer risk for carriers is very high, it is worth identifying through genetic testing when the family pattern suggests it.
Lynch Syndrome
Lynch syndrome is most commonly associated with colorectal and endometrial cancer, but research has found a modest association with lung cancer risk in some Lynch syndrome carriers. Lynch syndrome is caused by inherited changes in mismatch repair genes, including MLH1, MSH2, MSH6, and PMS2.
For most Lynch syndrome carriers, lung cancer monitoring is not the primary clinical focus. But in families with Lynch syndrome and a history of lung cancer, the combination is worth discussing with a genetic counselor.
BRCA2 and Other Genes
BRCA2, best known for its strong association with breast and ovarian cancers, has also been linked to a modestly elevated lung cancer risk in some studies. Similarly, CDKN2A, the primary hereditary melanoma gene, has been associated with elevated lung cancer risk in certain families.
These associations are less well established than those between these genes and their primary cancer types. But they are another reason why a comprehensive hereditary cancer panel, rather than a targeted single-gene test, gives a more complete picture of overall inherited cancer risk.
Hereditary Cancer Syndromes With Known Lung Cancer Associations
Syndrome
Caused By
Primary Cancers
Lung Cancer Link
Tier 1 Syndrome
Li-Fraumeni syndrome
Inherited TP53 gene change
Breast, brain, bone, soft tissue, adrenocortical
Established — lung cancer is part of the Li-Fraumeni cancer spectrum
Tier 1 Syndrome
Lynch syndrome
Inherited MLH1, MSH2, MSH6, or PMS2 gene change
Colorectal, endometrial, ovarian, gastric
Modest — some studies show elevated lung cancer risk in Lynch carriers
DNA Repair Gene
BRCA2
Inherited BRCA2 gene change
Breast, ovarian, prostate, pancreatic
Emerging — some studies link BRCA2 to modestly elevated lung cancer risk
Li-Fraumeni syndrome
Caused By
Inherited TP53 gene change
Primary Cancers
Breast, brain, bone, soft tissue, adrenocortical
Lung Cancer Link
Established — lung cancer is part of the Li-Fraumeni cancer spectrum
Lynch syndrome
Caused By
Inherited MLH1, MSH2, MSH6, or PMS2 gene change
Primary Cancers
Colorectal, endometrial, ovarian, gastric
Lung Cancer Link
Modest — some studies show elevated lung cancer risk in Lynch carriers
BRCA2
Caused By
Inherited BRCA2 gene change
Primary Cancers
Breast, ovarian, prostate, pancreatic
Lung Cancer Link
Emerging — some studies link BRCA2 to modestly elevated lung cancer risk
A comprehensive hereditary cancer panel covers all three of these syndromes in a single test. Identifying one of them has implications not just for lung cancer risk, but for multiple other cancer types as well.
Source: NCI, CDC
What Does Genetic Testing Tell You About Lung Cancer Risk?
Genetic testing gives you a broad picture of your overall inherited cancer risk. If a panel comes back positive for Li-Fraumeni syndrome, Lynch syndrome, a BRCA2 mutation, or another gene mutation associated with multiple cancer types, including lung, that information is clinically actionable across all those cancers, not just one.
A negative result does not eliminate the risk of lung cancer. Smoking remains the most significant risk factor for lung cancer. For people at high risk, low-dose CT screening remains the most evidence-supported screening approach.
Who Benefits Most From Hereditary Testing in This Context
Hereditary cancer risk testing is most likely to be informative and actionable for people who:
Have a family history pattern that includes lung cancer alongside other cancer types, particularly breast, colorectal, brain, or soft tissue cancers, which may indicate Li-Fraumeni or Lynch syndrome
Have a family member who was diagnosed with lung cancer at a young age without a significant smoking history
Have a known family member with a confirmed hereditary cancer syndrome, and want to know whether they inherited the same gene change
Are interested in understanding their complete inherited cancer risk picture across many cancer types, not just lung
What Are the Most Effective Prevention Steps for People With a Lung Cancer Family History?
Whether or not genetic testing reveals an inherited gene change, there are clear evidence-based steps for people with a family history of lung cancer.
Low-Dose CT Screening
Low-dose CT (LDCT) lung cancer screening is currently the most effective prevention tool for people at elevated lung cancer risk. Current guidelines from the U.S. Preventive Services Task Force recommend annual LDCT screening for adults aged 50 to 80 who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years.
For people with a significant family history of lung cancer, particularly those who have also smoked, discussing LDCT eligibility with a physician is an important step regardless of genetic testing results.
Smoking Cessation
Smoking remains responsible for approximately 80 to 90% of lung cancer cases. For people with a family history of lung cancer who also smoke, quitting is the single most impactful risk-reduction step available, and it is one that genetic testing cannot replace or substitute.
Radon Awareness
Radon, a naturally occurring radioactive gas that can accumulate in homes, is the second leading cause of lung cancer after smoking. It is estimated to cause approximately 21,000 lung cancer deaths annually in the United States. Testing your home for radon and mitigating elevated levels is a concrete, underutilized prevention step that is particularly relevant for non-smokers with a lung cancer family history.
Hereditary Cancer Risk Testing
For people whose family history suggests a hereditary syndrome may be present, a comprehensive hereditary cancer risk test can identify whether an inherited gene change is driving elevated risk across multiple cancer types. This is most informative when the family history includes lung cancer alongside other cancer types that suggest Li-Fraumeni or Lynch syndrome.
Kadance members receive access to hereditary cancer risk testing covering 26 clinically actionable genes, including TP53 (Li-Fraumeni syndrome) and the primary Lynch syndrome genes, through a CAP-accredited, CLIA-certified laboratory. The test includes genes for which results can help inform evidence-based medical next steps. Membership also includes access to genetic counseling to help members understand their results and support follow-up discussions with their physician.
FAQ: Genetic Testing for Lung Cancer and Family History
My parent had lung cancer. Should I get genetic testing?
It depends on the family pattern. If a parent was diagnosed with lung cancer and was a long-term smoker, the cancer was most likely caused by smoking rather than an inherited gene change, and hereditary testing is unlikely to be the most informative step. However, if your parent was a non-smoker or light smoker, was diagnosed young, or if other family members have had cancer across multiple types, a genetic counselor can review your family history and advise whether testing is clinically indicated.
Can lung cancer be passed to my children?
Lung cancer itself is not inherited. But if an inherited gene change contributed to a lung cancer diagnosis, that gene change can be passed to children. When a parent carries one of these gene changes, each child has a 50% chance of inheriting it. Hereditary cancer testing can help identify whether an inherited gene change is present, which may help other family members decide whether to consider testing.
Is there a specific genetic test for lung cancer?
There is no single genetic test designed specifically to assess lung cancer risk the way BRCA tests assess breast and ovarian cancer risk. The most relevant approach is a comprehensive hereditary cancer panel that covers genes associated with multiple cancer types, including those with known lung cancer associations such as TP53 and Lynch syndrome genes. A genetic counselor can review your family history and recommend the most appropriate panel.
What is the difference between hereditary testing and tumor testing for lung cancer?
Hereditary cancer testing analyzes the DNA you were born with to look for inherited gene changes that elevate cancer risk across your lifetime. It is a prevention and risk assessment tool. Tumor genomic testing, by contrast, analyzes gene changes in a cancer tumor after diagnosis to identify which treatments are most likely to work. These are completely different tests serving completely different purposes. This article focuses on hereditary testing for prevention. If you or a family member has been diagnosed with lung cancer, tumor genomic testing is a separate and important topic to discuss with the treating oncologist.
Who Should Ask About Genetic Testing for Lung Cancer?
If You Have a Lung Cancer Diagnosis
For people diagnosed with NSCLC, the immediate genetic testing priority is tumor genomic sequencing. Ask your oncologist:
'Has my tumor been tested for EGFR, ALK, ROS1, KRAS, and other targetable mutations?'
'Has PD-L1 expression and tumor mutational burden been assessed?'
'Is comprehensive molecular profiling (full NGS panel) appropriate for my tumor type and stage?'
These questions are the most clinically urgent. Germline hereditary testing may also be appropriate if personal or family history suggests a hereditary syndrome. Ask your oncologist or a genetic counselor to evaluate whether germline testing is indicated.
If Lung Cancer Runs in Your Family
For family members of lung cancer patients, the genetic testing picture is different. If the family pattern includes multiple lung cancers at young ages, or lung cancer combined with other cancers suggesting Li-Fraumeni syndrome or Lynch syndrome, a hereditary cancer panel may be appropriate.
A genetic counselor can review the complete family history and determine whether hereditary testing is clinically indicated. For most families with lung cancer, low-dose CT screening for high-risk individuals, not genetic testing, is the most evidence-supported preventive step.
Genetic Testing for Lung Cancer: Understanding Your Family History Is Worth the Conversation
If lung cancer has affected your family, a conversation with a physician or genetic counselor is an important place to start. They can review your family history, assess whether inherited risk may be relevant, and help guide appropriate next steps.
Kadance members receive access to hereditary cancer risk testing covering 26 clinically actionable genes, including TP53 (Li-Fraumeni syndrome) and the primary Lynch syndrome genes, through a CAP-accredited, CLIA-certified laboratory. Each gene included in the test is associated with evidence-based next steps if a positive result is found. Membership also includes access to genetic counseling to help members understand their results and support follow-up conversations with their physician. Depending on your history, other topics worth discussing may include low-dose CT screening eligibility, smoking cessation, and radon testing.
Understand your cancer risk. Get the genetic clarity that may change what comes next. Explore Kadance membership for access to hereditary cancer risk testing, genetic counseling, and the precision health infrastructure to make informed decisions for yourself and your family.
.svg)
